One of the initial aims of this study was to examine the potential of Brk to promote breast tumour growth, independent of exogenous influences such as HER2 expression, to eliminate the effect of HER2 in tumour growth, as most Brk expressing tumours are HER2 negative, and to establish whether the kinase function of Brk was required. The gene discussed is PTK6; the disease is breast neoplasm.